Mesalamine is an anti-inflammatory medication used primarily to treat ulcerative colitis, a chronic condition where the lining of the large intestine becomes inflamed and develops ulcers. It is FDA-approved for both inducing remission during active flare-ups and maintaining remission in adults with mild to moderate ulcerative colitis. It belongs to a class of drugs called 5-ASAs (5-aminosalicylic acids) and works directly on the intestinal lining rather than throughout the entire body.
How Mesalamine Treats Ulcerative Colitis
Mesalamine targets inflammation right where it starts: in the cells lining your colon. It blocks two key chemical pathways that produce prostaglandins and leukotrienes, substances your body makes that drive pain, swelling, and tissue damage during a flare. It also interferes with a protein called TNF-alpha, which normally ramps up inflammation by triggering a chain reaction inside intestinal cells. Mesalamine disrupts that chain reaction, preventing the signals that keep chronic inflammation going.
Because the drug acts locally in the gut, it tends to cause fewer body-wide side effects than medications that suppress the immune system more broadly. This local action is why mesalamine comes in several delivery forms designed to release the drug at specific points in the digestive tract.
Formulations and How They’re Used
Mesalamine is available as oral tablets, extended-release capsules, delayed-release capsules, rectal suppositories, and rectal enemas. The oral forms are coated or designed to dissolve at different locations in the intestine, depending on where your inflammation is. Rectal formulations are typically used for inflammation in the lower part of the colon (a pattern called ulcerative proctitis or left-sided colitis), while oral forms treat more widespread disease.
Your doctor may prescribe both an oral and a rectal form at the same time. A large review of 48 clinical trials involving over 8,000 patients found that combining oral and rectal mesalamine was the most effective strategy for inducing remission in mild to moderate ulcerative colitis. High-dose oral mesalamine (above 3 grams per day) was the next most effective approach, outperforming standard doses of 2 to 3 grams daily during active flares.
For long-term maintenance once a flare has settled, standard-dose mesalamine works just as well as higher doses. The 2025 American College of Gastroenterology guidelines recommend at least 1.5 grams per day of oral mesalamine for maintaining remission in left-sided or extensive colitis, and 1 gram daily of rectal mesalamine for proctitis.
What About Crohn’s Disease?
Mesalamine is sometimes prescribed for mild Crohn’s disease affecting the colon, but this is considered an off-label use. Its FDA approval is specifically for ulcerative colitis. Evidence for its effectiveness in Crohn’s disease is weaker, and current treatment guidelines generally favor other medications for that condition. If you have Crohn’s disease and are taking mesalamine, your gastroenterologist has likely weighed the limited evidence against your specific situation.
Common Side Effects
Most people tolerate mesalamine well, but it can cause digestive and general symptoms. The more common ones include nausea, heartburn, gas, constipation, and decreased appetite. Joint or muscle pain, back pain, dizziness, and cold-like symptoms (runny nose, sore throat, sneezing) also show up frequently. Some people experience hair thinning.
These side effects are generally mild and often improve as your body adjusts to the medication. If they persist or become bothersome, it’s worth discussing dose adjustments or switching formulations with your doctor.
Serious Reactions to Watch For
Rarely, mesalamine can cause more significant problems that need prompt medical attention. Signs of a serious allergic reaction include rash, hives, peeling or blistering skin, mouth sores, swelling of the face or throat, and difficulty breathing. Chest pain, new or worsening cough, and shortness of breath could indicate inflammation of the heart muscle or the sac around it, both rare but recognized complications.
Kidney problems are another concern with long-term use. Symptoms to watch for include painful or difficult urination, pink or red urine, blood in urine, or unexplained side or back pain. Yellowing of the skin or eyes, pale stools, or pain in the upper right abdomen can signal liver issues. Black or tarry stools and bloody vomit suggest gastrointestinal bleeding. Any of these warrant immediate contact with your healthcare provider.
Who Should Avoid Mesalamine
People with a known allergy to salicylates (the same family as aspirin) should not take mesalamine. This also applies to anyone allergic to related medications like balsalazide, olsalazine, or sulfasalazine. If you have existing kidney or liver disease, your doctor needs to know before prescribing it, as the drug can worsen these conditions.
Anyone who has received the chickenpox (varicella) vaccine within the past six weeks should avoid mesalamine due to a risk of Reye’s syndrome, a rare but serious condition affecting the brain and liver. People with a history of heart muscle inflammation or the sac around the heart should also flag this, as mesalamine can occasionally trigger or worsen these conditions. One specific formulation (Apriso extended-release capsules) contains aspartame, which is relevant for anyone with phenylketonuria.
Monitoring During Long-Term Use
Because mesalamine can affect the kidneys over time, regular blood work is part of staying on it safely. Before starting the medication, your doctor will check your baseline kidney function. That test is typically repeated at three months, then annually for as long as you’re on the drug. If you already have some degree of kidney impairment, testing happens more frequently. Some prescribing protocols call for checks as often as every two weeks initially, then monthly for the first few months before shifting to a quarterly schedule.
This monitoring is straightforward and involves routine blood draws. It’s one of the reasons mesalamine is considered a relatively low-maintenance medication compared to the immunosuppressive drugs used for more severe inflammatory bowel disease. Staying on schedule with these tests is the simplest thing you can do to catch any kidney changes early, when they’re easiest to address by adjusting your treatment.